Medical Hypotheses
Volume 58, Issue 2 , Pages 115-119, February 2002

Spontaneous regression: a hidden treasure buried in time

  • S.A. Hoption Cann

      Affiliations

    • Special Development Laboratory, Royal Jubilee Hospital, Victoria, British Columbia, Canada
    • Department of Biology, University of Victoria, Victoria, British Columbia, Canada
    • Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada
  • ,
  • J.P. van Netten

      Affiliations

    • Special Development Laboratory, Royal Jubilee Hospital, Victoria, British Columbia, Canada
    • Department of Biology, University of Victoria, Victoria, British Columbia, Canada
  • ,
  • C. van Netten

      Affiliations

    • Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada
  • ,
  • D.W. Glover

      Affiliations

    • Special Development Laboratory, Royal Jubilee Hospital, Victoria, British Columbia, Canada

Received 12 February 2001; accepted 5 July 2001.

Abstract 

Spontaneous tumor regression is a phenomenon that has been observed for hundreds, if not thousands of years. Although the term spontaneous implies ‘without apparent cause’, a review of case reports over the last several hundred years demonstrates that regression generally coincides with acute infections. Observations of this non-specific effect led to the emergence of active cancer immunotherapies by the 1700s. By the 1890s, William Coley refined this approach with a bacterial vaccine which, when administered properly, could induce complete regression of extensive metastatic disease. Unfortunately, after Coley's death, his vaccine and technique fell into obscurity.

Modern approaches to treatment have reduced the occurrence of spontaneous regressions. Aseptic techniques and antibiotics significantly reduce postoperative infections, while chemotherapy and radiation impair immune activation even when an infection does occur.

More than a century after its inception, Coley's vaccine and aggressive approach to treatment may still be one of most effective immunotherapies for cancer.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  • f1 Correspondence to: Stephen A. Hoption Cann, Department of Health Care and Epidemiology, University of British Columbia, 5804 Fairview Avenue, Vancouver, BC V6T 1Z3, Canada. Phone: +16048225688; Fax: +16048224994; E-mail: shopcann@interchange.ubc.ca

PII: S0306-9877(01)91469-0

doi:10.1054/mehy.2001.1469

Medical Hypotheses
Volume 58, Issue 2 , Pages 115-119, February 2002